FCMD
全球食品接触材料法规数据库
罗曲普坦琥珀酸盐(Frovatriptan)
(R)-(+)-6-carbamoyl-N-methyl-2,3,4,9-tetrahydro-1H-carbazol-3-aminium 3-carboxypropanoate monohydrate, (+)-(R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate (1:1),monohydrate, (+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1),monohydrate, Frovatriptan succinate [USAN], Frovatriptan Succinate monohydrate, UNII-D28J6W18HY, Frovatriptan succinate hydrate, 1H-Carbazole-6-carboxamide,2,3,4,9-tetrahydro-3-(methylamino)-,(R)-,butanedioate (1:1),monohydrate, (R)-frovatriptan succinate monohydrate
CAS号: 158930-17-7
IUPAC名称: butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
分子式: C18H25N3O6
分子量: 379.40800
InChI: InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1
InChIKey: CUETXFMONOSVJA-KLQYNRQASA-N
SMILES: CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
EINECS: -
免责声明 Disclaimer
1. CIRS努力保证内容的准确性并及时更新。但是,CIRS不对信息的质量、准确性、完整性或可靠性负责。
2. 在任何时候,CIRS不对因用户使用本数据库的信息导致的任何声明、损害或者损失负责以及承担责任。
3. CIRS保留在没有事先通知的情况下进行修改、修正、增加或者移除部分信息的权利。


